GLYCOMET 1 GM TAB

1. All Details: Specifications
Dosage Form: Film-coated sustained-release tablets.
Storage Conditions: Store below 30°C. Protect from light and moisture.
Batch Number: 60002691
Manufacturing Date (MFG. DATE): 02/2026
Expiry Date (EXPIRY DATE): 01/2028
Manufacturing License Number: Mfg. Lic. No.: G/25/2569
Maximum Retail Price (M.R.P.): Rs. 63.05 per 15 tablets (Inclusive of all taxes).
Internal Material Identifiers: 3016589 09/22
2. General
Brand: GLYCOMET® -1 GM (also printed in Devanagari script as ग्लाइकोमेट-१ जी एम).
Generic Name: Metformin Hydrochloride Sustained Release Tablets IP 1000 mg
Quantity: 15 Tablets (indicated by “15 Tablets” and “FOR 15 TABS.”).
Type: Allopathic Pharmaceutical / Prescription Drug (indicated by the statutory Schedule G and Schedule H red caution warning labels).
Form Factor: Blister strip containing solid oral tablets.
Maximum Shelf Life: 23 months (from February 2026 to January 2028).
Food Preference / FSSAI: Not Applicable. This product is a critical prescription medication for metabolic disease management, not a food product or a dietary supplement. Therefore, it is regulated by national drug control authorities rather than the FSSAI, and it does not display a vegetarian/non-vegetarian food preference mark.
3. Product Details: Ingredients
Each film-coated sustained-release tablet contains:
Metformin Hydrochloride IP: 1000 mg
Excipients: q.s. (Quantity Sufficient)
Colour: Titanium dioxide IP
4. Directions: How to Use
Dosage: As directed by the Physician.
Statutory Warning Labels:
SCHEDULE G PRESCRIPTION DRUG – CAUTION: It is dangerous to take this preparation except under Medical Supervision.
SCHEDULE H PRESCRIPTION DRUG – WARNING: To be sold by retail on the prescription of a Registered Medical Practitioner only.
5. DescriptionTherapeutic Application: GLYCOMET -1 GM is a high-strength sustained-release oral hypoglycemic medication containing Metformin Hydrochloride. It is standardly prescribed under strict medical supervision for management and glycemic control in individuals with Type 2 diabetes mellitus.
Packaging Design: The medication is sealed in a metallic blister strip designed to protect the sustained-release mechanism of the tablets from environmental moisture and light degradation. It prominently features standard dual-layered red cautionary grids to denote its scheduled prescription drug class.
6. Manufacturer Information
Mfd. by: USV Private Limited
Factory Address: Plot No. 538 to 540, 597 to 618, 619 to 625, GIDC Indl. Area-Savli, Taluka-Savli, Manjusar, Vadodara – 391 775.
7. Marketed By
Marketed By: USV Private Limited